J Korean Neuropsychiatr Assoc.
2001 Nov;40(6):1114-1121.
A Naturalistic Study of Atypical Antipsychotic Use in Inpatients with Bipolar I Disorder
- Affiliations
-
- 1Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Abstract
OBJECTIVES
This study was conducted to evaluate the prescription patterns, overall efficacy, and safety of atypical antipsychotics for inpatients with bipolar I disorder.
METHODS
Inpatients with bipolar I disorder, who had received adjunctive treatment with olanzapine or risperidone, beyond 1 month, along with mood stabilizers were selected for a retrospective study. The charts of those patients(N=56) were reviewed for the details of efficacy, safety, and other pharmacological variables of the two drugs.
RESULTS
Olanzapine and risperidone showed equivalent efficacy by the evaluation in accordance with clinical global impression scale (CGI) and global assessment of functioning scale(GAF) score. Different side effect profiles were noted between two drugs.
CONCLUSION
These limited results suggested that the efficacy and safety of risperidone and olanzapine were similar for the treatment of inpatients with bipolar I disorder. Prospective controlled study for efficacy and safety of risperidone and olanzapine in the treatment of bipolar I disorder should be conducted in future.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Trends in Pharmacotherapy of the Hospitalized Patients with Bipolar Disorder: A Twele-year Naturalistic Study
- Trends in the Prescribing of Antimanic Agents for Acute Manic Inpatients
- Quetiapine, Mood Stabilizer?
- Antipsychotic Drug Use Patterns for In-Hospital Treatment of Bipolar Disorder Patients
- A Trend of Drug Use in Inpatients with Bipolar Disorder: A 4-Year Naturalistic Study in One Hospital
